Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment.
about
Recent developments and future prospects in the treatment of visceral leishmaniasisMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisControl of visceral leishmaniasis in latin america-a systematic reviewCost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinentA poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appealArsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort studyDevelopment of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samplesLeishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeterVisceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategyWater-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and NepalLeishmaniasis: an update of current pharmacotherapy.Applied research for better disease prevention and control.An update on pharmacotherapy for leishmaniasisStudy of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasisHow do health care providers deal with kala-azar in the Indian subcontinent?Chemical and bioassay techniques to authenticate quality of the anti-leishmanial drug miltefosineFeasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex.Risk analysis and prediction of visceral leishmaniasis dispersion in São Paulo State, Brazil.Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India.Diagnosis of visceral leishmaniasis by polymerase chain reaction of DNA extracted from Giemsa's solution-stained slides.A series of case reports of autochthonous visceral leishmaniasis, mostly in non-endemic hilly areas of NepalAccurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined AntigensVisceral leishmaniasis: a forgotten epidemic.Lay perceptions of kala-azar, mosquitoes and bed nets in Bihar, India.Molecular and Serological Evidence of Leishmania Infection in Stray Dogs from Visceral Leishmaniasis-Endemic Areas of Bangladesh.Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine.What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis?Chemotherapeutics of visceral leishmaniasis: present and future developments.Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum.Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis.Evaluation of recombinant K39 antigen and various promastigote antigens in sero-diagnosis of visceral leishmaniasis in BangladeshEnvironmental Change and Kala-Azar with Particular Reference to Bangladesh
P2860
Q26740563-D5F3015E-12EA-408A-B2CC-F07054A76021Q28271849-CCD7DFCB-F5F4-4E6A-9423-6D3D85DA58F8Q28472552-C643FA9A-3ACC-4E1B-8FBB-FC925DC1B729Q28475431-23DC6C79-D81A-4E68-AF75-5AC0FFE3C509Q28483975-36BF4170-7D43-409B-8C59-D368318396E0Q28543757-D6F3F41B-5CAE-4E61-848E-6FB1D914008CQ29353857-F8BA692C-8AAA-4F09-9E90-C9BCD0E08E8BQ30423076-6317C120-A76D-4916-B950-A021A48E1ECBQ33401607-7F4B56B5-0F54-48F9-A194-43C5E64D2784Q33823803-FE856DC8-224F-40E2-A20D-B8E2562BE56AQ34043521-AE7A7B18-22D1-4EC3-8602-25DC20DF05E1Q34087309-74C11DA6-93D1-4709-9871-961AF12E7592Q34318765-947CBA37-4981-4521-ADFD-FCBF02D26DEAQ34874760-3763BB16-0498-4723-9F86-53BDCFE9FBA1Q34945204-F92924DE-8F94-487E-8ABD-C5EEBCB0094CQ35096895-150B7BDE-72B2-431E-9971-9DBA8519E3D0Q35351899-33557796-EBDF-4FE0-AB39-19E4AA94F448Q35681782-C2C599D4-97CD-4BD4-AFA0-33AAD8939846Q35844843-2E9A8FC0-8E9F-4E68-8A91-54914311147EQ35861438-BD1D930D-4ACB-4A83-BC59-C893BC3AE56BQ36271636-7C2D8BE5-832E-4643-B519-0398CE393D68Q38247916-F198181C-6712-4132-87A9-FBF437E85DD5Q38736545-6451E715-03EA-437D-9C74-4699FA0D6E1DQ39336023-47EEF347-4F20-4E2D-9BA8-D8DD80E17333Q39371328-5E9EDA99-EEA6-42DF-B85B-96CCC6940F41Q39577607-7A304528-8F45-4DED-9136-B01822D4E326Q39632056-CE756362-45D6-4AE2-8183-A483BB0C1F6EQ40355083-AA6346D0-3EE9-4593-8DA6-7D0E044B044BQ40624106-0A18568A-AACD-4B5E-AE03-4D02FF1F6AD4Q43577504-404D0100-7DC1-4E0C-B019-EF7266A6C0E0Q44920807-C87DEF19-8AD4-4AED-B5A6-5764231F2B6AQ46713325-0BD9DC84-A840-4BCE-9C0A-2EB29BB9CD3FQ46921246-C141F4FE-C84C-429D-A9B6-DDA65EAB1BFDQ54961274-A637F249-E199-45F3-9F3F-F86BA2D06285Q55464876-6151490D-7BB6-4551-989F-AC27EAA57A45Q56463030-818A07AA-8ACD-443F-A72D-519E73AE86E8Q57927348-58F1E8C8-DEFC-4AB3-9904-D90F18A7A5D1
P2860
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Implementation research to sup ...... s for diagnosis and treatment.
@en
Implementation research to sup ...... s for diagnosis and treatment.
@nl
type
label
Implementation research to sup ...... s for diagnosis and treatment.
@en
Implementation research to sup ...... s for diagnosis and treatment.
@nl
prefLabel
Implementation research to sup ...... s for diagnosis and treatment.
@en
Implementation research to sup ...... s for diagnosis and treatment.
@nl
P2093
P50
P921
P1476
Implementation research to sup ...... s for diagnosis and treatment.
@en
P2093
Gundel Harms
Hashim Ghalib
Heide Richter-Airijoki
Philippe Desjeux
Sujit Bhattacharya
Suman Rijal
P356
10.1111/J.1365-3156.2007.01974.X
P577
2008-01-01T00:00:00Z